Lacktman, Wein Discuss New Telehealth Reimbursement Codes
November 12, 2019
mHealth Intelligence
Partner Nate Lacktman and Of Counsel Emily Wein were quoted in an mHealth Intelligence article, “CMS Expands Telehealth Coverage for Opioid Abuse Disorder Treatment,” about the adoption of new reimbursement codes that will allow providers to bill Medicare for telehealth services to treat opioid abuse, including care delivered to the home.
Lacktman and Wein, writing in a blog post, said the new codes, combined with recent legislation removing geographic limitations for telehealth services to individuals diagnosed with a substance abuse disorder, will provide new opportunities to deliver care to the patient’s home. “No originating site facility fee is paid when the beneficiary’s home is the originating site,” they wrote.
People
Related News
August 19, 2025
In the News
Gustavo Resendiz Featured in Q&A on Secondary Market Momentum – 'Investors want liquidity'
Foley & Lardner LLP partner Gustavo Resendiz is featured in the Crunchbase News Q&A, "Why Secondary Funds Still Can’t Keep Up With Investor Demand," lending insight into the accelerating investor momentum towards secondary transactions.
August 18, 2025
In the News
David Simon Coauthors Piece on Empowering Lawyers as Strategic Business Partners
Foley & Lardner LLP partner David Simon coauthored The Agenda article, "Turn Your Corporate Lawyer into a Strategic Weapon," published by Financial Times.
August 15, 2025
In the News
Gregory Husisian on Voluntary Disclosures to Customs – 'Importing has never been riskier'
Foley & Lardner LLP partner Gregory Husisian authored the SupplyChainBrain article, "Best Practices for Making Voluntary Disclosures to Customs," sharing insight on this vital strategy for companies looking to mitigate risk from U.S. Customs and Border Protection.